Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Oxidative Medicine and Cellular Longevity|May 27, 2022
Sitagliptin Alleviates Radiation-Induced Intestinal Injury by Activating NRF2-Antioxidant Axis, Mitigating NLRP3 Inf--lammasome Activation, and Reversing Gut Microbiota DisorderShanshan Huang, Yongbiao Huang, Wanling Lin, et al.
RSC Advances|October 15, 2024
A self-regulated shielding layer induced by an electrolyte additive for alkaline Al-air batteriesLei Guo, Yongbiao Huang, Ida Ritacco, et al.
Cancers|December 11, 2022
Comprehensive Pan-Cancer Analyses of Immunogenic Cell Death as a Biomarker in Predicting Prognosis and Therapeutic ResponseYuan Wang, Yongbiao Huang, Mu Yang, et al.
Oncoimmunology|January 18, 2021
Pirfenidone facilitates immune infiltration and enhances the antitumor efficacy of PD-L1 blockade in miceWan Qin, Jun Zou, Yongbiao Huang, et al.
Clinical Epigenetics|April 29, 2023
Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinomaYongbiao Huang, Lingyan Xiao, Motuma Yigezu Daba, et al.
Cell Death & Disease|November 17, 2024
ADAMTS16 drives epithelial-mesenchymal transition and metastasis through a feedback loop upon TGF-β1 activation in lung adenocarcinomaLingyan Xiao, Qian Li, Shuaijun Chen, et al.
Frontiers in Cell and Developmental Biology|April 11, 2022
Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach AdenocarcinomaMin Fu, Yongbiao Huang, Xiaohong Peng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 26, 2025
Genetic Regulation of Alternative Polyadenylation Provides Novel Insights into Molecular Mechanisms Underlying Non-small Cell Lung CancerMeng Jin, Yongbiao Huang, Bin Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 26, 2025
Camouflaged Nanozymes with Oxidation-Promoting Activities Triggering Ferroptosis for Radio-ImmunotherapyKun Qiao, Yongbiao Huang, Shipeng Ning, et al.
Frontiers in Immunology|January 3, 2022
PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic CancerYali Wang, Kun Zheng, Hua Xiong, et al.
Pageof 5